Sinecatechins

赛儿茶素

Report date: 2022/01/14 13:23:58
NMEFirst In Class

Base Information

Drug NameSinecatechins
Drug Alias NameKunecatechinssinecatechinsVeregenPolyphenon ESB-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsVirus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsVulvar and vaginal atrophySolid tumoursMenopausal symptoms +[33] 
Global Approved IndicationsWarts
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2006/10/31
Country/TerritoryCanadaUnited StatesRomania +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsui Norin
China Registration ClassN/A

Develop Information

Active CompaniesAresus Pharma GmbHNational Cancer InstituteFougera Pharmaceuticals Inc
Inactive CompaniesMaastricht University Medical CenterNational Center For Complementary And Integrative HealthThe University Of Arizona +[12] 
Active IndicationsLiver CirrhosisKeratosis, ActinicProstatic Neoplasms +[4] 
Inactive IndicationsVulvar and vaginal atrophySolid tumoursMenopausal symptoms +[29] 

Other Information

ATC CodeD06BB12
Related LinksWikipediaDrugBankKEGG